AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 5 added, 4 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $186.87
- 52-wk high
- $194.59
- High
- $189.03
- 52-wk low
- $111.78
- Low
- $186.47
- Prev close
- $188.58
- Mkt cap
- $24.46B
- P/E
- 27.5x
- Volume
- 764.5K
- Fwd P/E
- 24.4x
- Beta
- 1.06
- Div yield
- 0.84%
- P/S
- 2.0x
- P/B
- 11.5x
- Profit margin
- +7.6%
- Op margin
- +10.7%
- ROE
- +42.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about EXPD filings
Are insiders buying or selling Expeditors International of Washington, Inc. (EXPD) stock?
Neither. Expeditors International of Washington, Inc. (EXPD) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded EXPD recently?
None. No member of Congress disclosed a EXPD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this EXPD smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (3)
- BA
Balyasny
$97.4M
added
- CI
Citadel
$95.6M
added
- P7
Point72
$39.2M
bought
How top traders are positioned
No tracked top-trader positions in EXPD right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 20.8% above what analysts expected.
Earnings per share
$1.68 expected
Reports Nov 3, 2026, in 33 days
Estimates as of Sep 30, 2026
EPS expected
$1.75 to $2.42
Revenue expected
12 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.89B | $2.86B | $2.78B | $3.50B |
| Cost of what it sold | $2.43B | $2.44B | $1.81B | $2.48B |
| Gross profit | $464.7M | $413.3M | $971.8M | $1.03B |
| What it spent | ||||
| Sales and admin | $9.7M | $11.9M | $666.6M | $666.6M |
| Other operating costs | $167.0M | $150.4M | $10.4M | $9.9M |
| Total operating expenses | $176.6M | $162.4M | $677.0M | $676.5M |
| What was left | ||||
| Operating profit | $288.0M | $250.9M | $294.8M | $349.6M |
| Profit before tax | $298.2M | $262.0M | $306.5M | $357.4M |
| Tax | $75.1M | $61.1M | $76.4M | $91.2M |
| Net profit | $222.3M | $201.2M | $229.6M | $266.2M |
| EBITDA | $312.4M | $276.1M | $305.7M | $365.3M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
4% Overvalued? Expeditors International Of Washington (EXPD) On Leadership Change
NeutralSep 30This Ciena Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
NeutralSep 30BNP Paribas Initiates Expeditors International of Washington at Neutral With $180 Price Target
NeutralSep 30BNP Paribas Exane initiates Expeditors stock with neutral rating By Investing.com
NeutralSep 30BNP Paribas Exane initiates Expeditors stock with neutral rating By Investing.com
NeutralSep 30Ryanair Holdings plc (RYAAY) latest stock news and headlines – Yahoo Finance
NeutralSep 30Delta Expands Europe Network With New Routes From Detroit and Boston
BullishSep 29Zacks.com featured highlights include CNXN, ECG, GRDN, EXPD and PBF
Leans bullishSep 29